Stability and toxicity of heteroleptic organometallic Bi(v) complexes towards Leishmania major

Novel Triphenylantimony(V) and Triphenylbismuth(V) Complexes with Benzoic Acid Derivatives: Structural Characterization, in Vitro Antileishmanial and Antibacterial Activities and Cytotoxicity against Macrophages

(2014) Arshad Islam et al.   MOLECULES

Cytotoxicity andIn VitroAntileishmanial Activity of Antimony (V), Bismuth (V), and Tin (IV) Complexes of Lapachol

(2013) Marcele Neves Rocha et al.   BIOINORGANIC CHEMISTRY AND APPLICATIONS

Lipophilic bismuth phosphates: a molecular tetradecanuclear cage and a 1D-coordination polymer. Synthesis, structure and conversion to BiPO4

(2013) Vadapalli Chandrasekhar et al.   DALTON TRANSACTIONS

Anti-leishmanial activity of heteroleptic organometallic Sb(v) compounds

(2013) Muhammad Irshad Ali et al.   DALTON TRANSACTIONS

Bismuth(iii) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents

(2013) Philip C. Andrews et al.   DALTON TRANSACTIONS

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

(2012) T. P. C. Dorlo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Structural motifs in phenylbismuth heterocyclic carboxylates – secondary interactions leading to oligomers

(2011) O. Anjaneyulu et al.   DALTON TRANSACTIONS

Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates

(2010) Philip C. Andrews et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Leishmaniasis: Current Treatment and Prospects for New Drugs and Vaccines

(2009) Lukasz Kedzierski et al.   CURRENT MEDICINAL CHEMISTRY

Pentavalent Antimonials: New Perspectives for Old Drugs

(2009) Frédéric Frézard et al.   MOLECULES